Effect of spironolactone and ethylestrenol on benzo(a)pyrene hydroxylase (EC 1.14.1.1) and other chemical constituents of hepatic microsomes.
D000818:Animals; D001580:Benzopyrenes; D003580:Cytochromes / Q000378:metabolism; D005032:Ethylestrenol / Q000494:pharmacology*; D005260:Female; D005470:Fluorometry; D007215:Indophenol; D008099:Liver / Q000166:cytology / Q000201:enzymology; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009249:NADP; D010088:Oxidoreductases / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D010636:Phenols; D010743:Phospholipids / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013053:Spectrophotometry; D013148:Spironolactone / Q000494:pharmacology*; D013347:Subcellular Fractions / Q000201:enzymology
D001580:Benzopyrenes; D003580:Cytochromes; D010636:Phenols; D010743:Phospholipids; D011506:Proteins; D013148:Spironolactone; D007215:Indophenol; D009249:NADP; D005032:Ethylestrenol; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D010634:Phenobarbital